ライフサイエンスコーパス: fetal liver

1 rterial clusters (IAC) before colonizing the fetal liver.

2 maturing erythroblast populations within the fetal liver.

3 This structure appears conserved in mouse fetal liver.

4 defects in definitive erythropoiesis in the fetal liver.

5 or cells (EPCs) in human bone marrow and the fetal liver.

6 highly reminiscent of erythropoiesis in the fetal liver.

7 progenitor and hematopoietic stem cells from fetal liver.

8 is in the yolk sac and its transition to the fetal liver.

9 undance of these cells in the late gestation fetal liver.

10 that primitive RBCs in mice enucleate in the fetal liver.

11 rrelating with erythropoiesis defects in the fetal liver.

12 omal cells that support HSC expansion in the fetal liver.

13 sential for definitive erythropoiesis in the fetal liver.

14 derived from the embryonic yolk sac and from fetal liver.

15 nd CYP26B1 enzymes is expressed in the human fetal liver.

16 in the dorsal aorta and fail to colonize the fetal liver.

17 tion day E18 human beta-YAC transgenic mouse fetal liver.

18 pressed in the cytoplasm of human and rodent fetal livers.

19 is sufficient to induce expansion of MEPs in fetal livers.

20 forkhead box class O (FOXO)1 in CON and IUGR fetal livers.

21 livers and that derive from ductal plates in fetal livers.

22 weeks of gestation were found for the human fetal livers.

23 s there was no significant difference in the fetal liver (2.72 msec vs 3.18 msec; P = .47).

24 ated with hematopoietic abnormalities in the fetal liver, a preleukemic condition termed transient my

25 ur fate-mapping experiments identify, in the fetal liver, a sequence of yolk sac EMP-derived and HSC-

26 In the fetal liver, a subset of common lymphoid progenitors (CL

27 uantitatively compare the proteomes of human fetal liver, adult hepatocytes, and the HepG2 cell line.

28 hypothesized that CYP26 enzymes in the human fetal liver also function as a protective barrier to pre

29 However, the fetal liver also produces hepcidin, which may regulate f

30 ion of 11beta-HSD1 and reductase activity in fetal liver and adipose tissues.

31 so regulates GATA-2 expression in definitive fetal liver and adult BM HSCs, and that GATA-2 function

32 Mouse B cell precursors from fetal liver and adult bone marrow (BM) generate distinct

33 Fetal liver and adult bone marrow hematopoietic stem cel

34 novel subset of lymphoid precursors in mouse fetal liver and adult bone marrow that transiently expre

35 CD45R(low/-)CD19(+) progenitor found both in fetal liver and adult bone marrow.

36 s important roles in normal hematopoiesis in fetal liver and adult bone marrow.

37 functional consequence of ARNT deficiency on fetal liver and adult hematopoiesis.

38 Cited2 is an essential regulator in fetal liver and adult hematopoiesis.

39 erythropoiesis occurs in the murine spleen, fetal liver and adult liver.

40 in embryonic day 13.5 and embryonic day 18.5 fetal liver and adult spleen and bone marrow cells, resp

41 genes such as Fgf21 remain repressed in the fetal liver and become PPARalpha responsive after birth

42 Using fetal liver and BM congenic transplantations and deletin

43 Fetal liver and BM-derived CD34(+)ACE(+) cells, but not

44 l antibody support ex vivo expansion of both fetal liver and bone marrow hematopoietic stem cells (HS

45 how regulation of different progenitors from fetal liver and bone marrow may play a role in the age-r

46 BI formation is regulated differently in the fetal liver and bone marrow.

47 ,000 human immunophenotypic blood cells from fetal liver and bone marrow.

48 ean placental TTP negatively correlated with fetal liver and brain volumes at the time of MRI as well

49 phoid tissue inducer cell progenitors in the fetal liver and common lymphoid progenitors in the bone

50 was used to reseed the scaffolds with human fetal liver and endothelial cells.

51 of definitive hematopoiesis, such as in the fetal liver and fetal bone marrow, is not known.

52 etic stem/progenitor cell compartment in the fetal liver and for essential vascular processes.

53 ed exclusively during pregnancy by the human fetal liver and initially considered as a weak estrogen.

54 increases steatosis and oxidative stress in fetal liver and is associated with lifetime disease risk

55 natural killer (NK) cells arise in the mouse fetal liver and persist in the adult liver.

56 fetal protein that is expressed in the human fetal liver and silenced in the adult liver, but it is r

57 - and Mrtf-deleted animals, hematopoiesis in fetal liver and spleen is intact but does not become est

58 Here we show that HSCs in murine fetal liver and the bone marrow are of two types that ca

59 ors among common lymphoid progenitors in the fetal liver and the bone marrow.

60 is is reconstituted by implantation of human fetal liver and thymus tissue (Thy/Liv) plus intravenous

61 is specifically expressed in mouse and human fetal liver and thymus, but not in adult bone marrow or

62 me 99), that is expressed in bone marrow and fetal liver and whose expression is also induced in peri

63 most entirely eliminated pro-B cells in both fetal livers and adult bone marrow, resulting in a sever

64 hyperoxygenation for live FPUs in placenta, fetal liver, and brain.

65 We apply this method in mouse fetal liver, and identify de novo cell-type-specific chr

66 educed erythroid colony forming cells in the fetal liver, and low Bag1 expression impairs erythroid d

67 regions of interest of the entire placenta, fetal liver, and maternal liver.

68 ed in the embryonic yolk sac, but not in the fetal liver; and wild-type beta-globin was co-expressed

69 show that CD11b(HI) macrophages derived from fetal liver are the major pro-inflammatory cells in the

70 progenitors located within the yolk sac and fetal liver as well as definitive hematopoietic stem cel

71 ata2 mutant embryos involved HSC loss in the fetal liver, as demonstrated by in vitro colony-forming

72 ., the aorta-gonad-mesonephros (AGM) and the fetal liver at 10.5-11.5 dpc, and found that only a rare

73 c progenitor cells available for seeding the fetal liver at E11.

74 the bloodstream of E10.5 embryos and in the fetal liver at E11.5 to E13.5.

75 5(-) NK-cell progenitor (NKP) emerges in the fetal liver at E13.5.

76 type 3, whereas murine HNF6 participates in fetal liver B lymphopoiesis.

77 mble and wt mice displayed similar levels of fetal liver B-1 progenitors and splenic neonatal transit

78 ay (E) 8.5, migrate and colonize the nascent fetal liver before E10.5, and give rise to fetal erythro

79 re red blood cells in cultures of both mouse fetal liver BFU-Es and mobilized human adult CD34(+) per

80 bodies cloned from single B cells from human fetal liver, bone marrow, and spleen.

81 H3K14ac and DBC1-SIRT1 complex formation in fetal livers, both of which were abrogated with diet rev

82 tal phenotype with beneficial effects in the fetal liver but an unexplained and concerning alteration

83 HSCs emerge and successfully migrate to the fetal liver but are decreased in frequency by embryonic

84 HAMP is also expressed in the fetal liver but its role in controlling fetal iron store

85 endothelium of the dorsal aorta and then the fetal liver but what regulates this switch is unknown.

86 hese abnormalities overlap with those of T21 fetal livers, but also reflect important differences.

87 that IRF2-occupied genes identified in human fetal liver CD34(+) HSPCs are actively transcribed in hu

88 ing following HCV infection of primary human fetal liver cell (HFLC) cultures from 18 different donor

89 ture hepatocytes in adult liver (adult HCs), fetal liver cells (FLCs), induced hepatic stem cells (iH

90 e demonstrate that primary cultures of human fetal liver cells (HFLC) reliably support infection with

91 an inflammatory cytokine expressed by human fetal liver cells (HFLCs) after infection with cell cult

92 ed expression of HAI-1 and -2 transcripts in fetal liver cells and this induction could be antagonize

93 Lack of STAT5 in fetal liver cells caused rapid differentiation and loss

94 Fetal liver cells derived from low-density-lipoprotein r

95 All mice transplanted with fetal liver cells ectopically expressing miR-125b showed

96 leukemic pathology in mice transplanted with fetal liver cells expressing translocated in liposarcoma

97 genitor cells, because Vav-iCre Ripk1(fl/fl) fetal liver cells failed to reconstitute hematopoiesis i

98 Fetal liver cells from Cited2 null embryos give rise to

99 Fetal liver cells from Dusp16tp/tp embryos efficiently r

100 ion of human fetal thymic tissue and CD34(+) fetal liver cells in nonobese diabetic (NOD)/severe comb

101 topoietic reconstitution with Mafb-deficient fetal liver cells in recipient LDL receptor-deficient hy

102 Transplantation of Bv8 null fetal liver cells into lethally irradiated hosts also re

103 e present study, we transplanted necdin-null fetal liver cells into lethally irradiated recipients.

104 Previously we showed that the ~2% of fetal liver cells reactive with an anti-CD3epsilon monoc

105 sed embryonic lethality, and Srsf2-deficient fetal liver cells showed significantly enhanced apoptosi

106 They are also the principal fetal liver cells that express CXCL12, a factor required

107 These are the principal fetal liver cells that express not only angiopoietin-lik

108 t mice transplanted with NP23 bone marrow or fetal liver cells that had been transduced with a Bcor s

109 Bone marrow transplantation of SENP1 KO fetal liver cells to irradiated adult recipients confers

110 Bone marrow cells and, alternatively, fetal liver cells were cultured in media containing M-CS

111 When murine fetal liver cells were transduced with either of the hum

112 macrophage-specific markers CD 11b, F4/80 in fetal liver cells, and bone marrow-derived macrophages w

113 rsist when Runx1 is conditionally deleted in fetal liver cells, demonstrating that the requirement fo

114 Furthermore, we observe that in PU.1(-/-) fetal liver cells, low levels of the IE GATA-1 isoform i

115 r hematopoietic abnormalities in Klotho(-/-) fetal liver cells, suggesting that the effects of klotho

116 were 275-fold higher, compared with unsorted fetal liver cells, when 3 reprogramming factors were tra

117 oth murine erythroleukemia cells, as well as fetal liver cells, whereas an increase in PIAS3 levels i

118 enes genome-wide in embryonic stem cells and fetal liver cells.

119 munodeficient mice in the presence of scurfy fetal liver cells.

120 angiopathies by exploring their functions in fetal liver cells.

121 between the three-dimensional liver bud and fetal liver cells.

122 most marked effects, disturbing maternal and fetal liver chemical profiles, masculinising fetal anoge

123 amoxifen-induced depletion or by Bcl11b(-/-) fetal liver chimera reconstitution, demonstrates that IL

124 KI/KI) mice die neonatally, but Orai1(KI/KI) fetal liver chimeric mice are viable and show normal lym

125 electrophysiological properties of scars in fetal liver chimeric mice generated using connexin43 kno

126 Irradiated fetal liver chimeric mice reconstituted with Gimap5-defi

127 d HSCs, and whether that transition requires fetal liver colonization, we performed conditional, time

128 least a subset of HSCs that does not require fetal liver colonization.

129 are largely methylated at CpG residues among fetal liver common lymphoid progenitor cells.

130 Fetal liver concentration of Cbl reflects nutritional st

131 Human T21 fetal livers contain expanded erythro-megakaryocytic pre

132 Fetal liver contained large numbers of distinct oligopot

133 ristic differences between HSCs derived from fetal liver, cord blood, bone marrow, and peripheral blo

134 plication was not observed in primary equine fetal liver cultures or after electroporation of selecta

135 Intra-hepatic transfer of human fetal liver derived hematopoietic stem and progenitor ce

136 When isolated from liver or lung, CD11b(HI) fetal liver derived macrophages responded to the TLR4 ag

137 vivo due to defective endocytic pathway, and fetal liver-derived Dnm2-null MKs formed proplatelets po

138 ression in terminally differentiating murine fetal liver-derived erythroid cells to identify regulato

139 ogous fetal lymphoid tissues, and autologous fetal liver-derived hematopoietic stem cells.

140 mod3 regulates F-actin organization in mouse fetal liver-derived MKs, thereby controlling MK cytoplas

141 Finally, in wild-type mature murine fetal liver-derived MKs, Wnt3a potently induced proplate

142 By taking advantage of two fetal liver-derived stromal lines with widely differing

143 y, we examine the localization of YAP during fetal liver development and show that higher levels of Y

144 P-gp was completely inhibited, the brain and fetal liver distribution clearance (K1) approximated tis

145 model best explained the observed brain and fetal liver distribution of (11)C-radioactivity.

146 c enhancer (-10E) that displayed activity in fetal liver, dorsal aorta, vitelline vessels, yolk sac,

147 e a shift in the haemopoietic composition of fetal liver during gestation away from being predominant

148 NAs, we compared gene knockout and wild-type fetal liver erythroblasts by RNA sequencing, quantitativ

149 These early fetal liver erythroblasts express predominantly adult be

150 Knockdown of Xpo7 in primary mouse fetal liver erythroblasts resulted in severe inhibition

151 Flow cytometry of fetal liver erythroblasts shows that late-stage populati

152 Tmod1 leads to enucleation defects in mouse fetal liver erythroblasts, and in CD34(+) hematopoietic

153 4 is important for the maturation of primary fetal liver erythroid cells.

154 n alone plays a significant role in terminal fetal liver erythroid differentiation.

155 Fetal liver erythroid precursors of Ccbe1 null mice exhi

156 Knockdown of Mbnl1 in cultured murine fetal liver erythroid progenitors resulted in a strong b

157 d during ex vivo differentiation of Hri(-/-) fetal liver erythroid progenitors.

158 cy resulted in porphyrin accumulation in the fetal liver, erythroid maturation arrest, and embryonic

159 titution studies suggest that CCBE1 promotes fetal liver erythropoiesis cell nonautonomously.

160 In contrast to the profound effects on fetal liver erythropoiesis, postnatal deletion of Ccbe1

161 E1 plays an essential role in regulating the fetal liver erythropoietic environment and suggest that

162 The mutant bone marrow and fetal liver exhibited severe deficiency in HSCs and hema

163 Gata4 knockout fetal livers exhibited reduced size, advanced fibrosis,

164 cell progenitors emerging in the E13.5 mouse fetal liver express the colony-stimulating factor-1 rece

165 esis, we examined the number and function of fetal liver (FL) and bone marrow cells.

166 UHCT would mobilize endogenous HSCs from the fetal liver (FL) and result in preferential FL homing of

167 ematopoietic progenitor cells migrate to the fetal liver (FL) between gestational days (E) 9.5 and 10

168 enitor (MkP) hyperproliferation during early fetal liver (FL) hematopoiesis, but not during postnatal

169 rategy and fate-mapping of yolk sac (YS) and fetal liver (FL) hematopoiesis.

170 d with primary disomic controls, primary T21 fetal liver (FL) hematopoietic stem cells (HSC) and mega

171 that of native LKS cells isolated from mouse fetal liver (FL) or bone marrow (BM).

172 Macrophages and erythroid cells in the fetal liver (FL) were also decreased after midgestation

173 HSCs first migrate to the fetal liver (FL), where they expand, before they seed th

174 Before birth, B cells develop in the fetal liver (FL).

175 (AGM) and mature as they transit through the fetal liver (FL).

176 poietic stem cells (HSCs) accumulated in the fetal liver following geminin ablation, while committed

177 d to PPAR signaling pathways in maternal and fetal livers ([Formula: see text]).

178 r with androgen excess, affects maternal and fetal liver function as demonstrated by increased trigly

179 les characterized by increased expression of fetal liver genes including alpha-fetoprotein.

180 f a maternal HF diet on molecular markers of fetal liver gluconeogenesis.

181 Our integrated map of fetal liver haematopoiesis provides a blueprint for the

182 Thus, fetal liver HAMP operates cell-autonomously to increase

183 in the placenta is not actively regulated by fetal liver HAMP under normal physiological conditions.

184 uely present in a narrow window of embryonic fetal liver hematopoiesis and do not persist in adult bo

185 expression decreased with the termination of fetal liver hematopoiesis, and this decrease correlated

186 lved in various biologic processes including fetal liver hematopoiesis.

187 itors that seed the skin before the onset of fetal liver hematopoiesis.

188 mal mitochondrial respiration) caused lethal fetal liver hematopoietic defects and hematopoietic stem

189 Chimeric mice generated with Gata3-deficient fetal liver hematopoietic precursors lack all intestinal

190 requires cell-intrinsic Gata3 expression in fetal liver hematopoietic precursors.

191 c expression and KD of miR-486-5p in primary fetal liver hematopoietic progenitors demonstrated that

192 Flt3Cre+ KrasG12D fetal liver hematopoietic progenitors give rise to a mye

193 tative deficiencies in the murine Fancc(-/-) fetal liver hematopoietic stem and progenitor cell pool.

194 Fancc(-/-) fetal liver hematopoietic stem and progenitor cells reve

195 identify intrinsic biases in the activity of fetal liver hematopoietic stem cell (HSC) clones and to

196 chimeric mice generated with Gata3-deficient fetal liver hematopoietic stem cells fail to develop sys

197 tein GPI-80 defines a subpopulation of human fetal liver hematopoietic stem/progenitor cells (HSPCs)

198 and primary erythroblasts (ERY) from murine fetal liver hematopoietic stem/progenitor cells.

199 primordial gallbladder epithelia but not in fetal liver hepatoblasts.

200 lk1-Gtl2 locus are predominantly enriched in fetal liver HSCs and the adult LT-HSC population and sus

201 ow hematopoietic stem cells (HSCs), although fetal liver HSCs are produced in normal numbers.

202 We show that ex vivo-matured and fetal liver HSCs express programmed death ligand 1 (PD-L

203 In addition, TAD-deficient fetal liver HSCs fail to compete with wild-type HSCs in

204 Ex vivo matured HSCs more closely resemble fetal liver HSCs than pre-HSCs, but are not their molecu

205 n of prehematopoietic stem cells (pre-HSCs), fetal liver HSCs, and adult bone marrow HSCs.

206 4) describe a novel surface marker for human fetal liver HSCs, glycosylphosphatidylinositol-anchored

207 of a Gata2 cis-element (+9.5) that depletes fetal liver HSCs, is lethal at E13-14 of embryogenesis,

208 tomes of pre-HSCs, HSCs matured ex vivo, and fetal liver HSCs.

209 ent has been shown to cause a severe loss of fetal liver HSCs; however, the underlying mechanisms and

210 uencies of 17% and 26%, respectively, and in fetal liver HSPCs at 19% and 43%, respectively.

211 Manipulation of RLR expression in mouse fetal liver HSPCs indicated functional conservation amon

212 ng to intrauterine fetal growth restriction, fetal liver hypocellularity, and demise.

213 ith down-regulation of PU.1 and GATA2 in the fetal liver, impeding a key step required for commitment

214 cells (HSCs) located in adult bone marrow or fetal liver in mammals produce all cells from the blood

215 Fetal liver injury in NH cases is associated with a seve

216 notypic expression of gestational alloimmune fetal liver injury.

217 HAMP operates cell-autonomously to increase fetal liver iron stores.

218 of the tyrosine kinase activity of VEGFR-2 (fetal liver kinase 1, kinase insert domain-containing re

219 nism, requires paracrine VEGF stimulation of fetal liver kinase 1-Notch signaling, and adult collater

220 lial growth factor receptor-2, also known as fetal liver kinase-1 (FLK1).

221 Repopulation of LC-deficient mice using fetal liver LC-precursors restores DMBA-induced tumor su

222 entiation conditions favoring development of fetal liver-like, gamma-globin expressing, definitive he

223 Comparison of adult bone marrow to fetal liver lysates demonstrated developmental silencing

224 We evaluated fetal testes, maternal and fetal livers, maternal serum clinical chemistry, and rep

225 topoietic stem cells (HSCs) expanding in the fetal liver migrate to the developing bone marrow (BM) t

226 quently, adult LCs derive predominantly from fetal liver monocyte-derived cells with a minor contribu

227 wth after birth, and are mainly derived from fetal liver monocytes before birth, but self-maintain th

228 erived LC precursors are largely replaced by fetal liver monocytes during late embryogenesis.

229 lation changes can be detected in trisomy 21 fetal liver mononuclear cells, prior to the acquisition

230 PLCSCs were directly compared to fetal liver MSCs (flMSCs).

231 ow has been characterized, the nature of the fetal liver niche is not yet elucidated.

232 (E10.5 and E11.5) AGM or derived from E13.5 fetal liver not only differentiate into hematopoietic co

233 tudies revealed a severely dilated ER in the fetal liver of mutant embryos, indicative of alteration

234 GATA1-dependent genes are down-regulated in fetal liver of SENP1 KO mice.

235 pmentally mature, definitive HSCs from E14.5 fetal liver or adult bone marrow (BM) more robustly engr

236 -10 production, or differences between their fetal liver or adult bone marrow progenitor cell origins

237 macrophages and NK cells derived from human fetal liver or adult CD34(+) progenitor cells injected i

238 icantly higher in maternal serum than in the fetal liver or placenta after lipid-adjustment (p < 0.00

239 r development, without any contribution from fetal liver or postnatal hematopoiesis.

240 Stem/progenitor cells derived from fetal livers or mature hepatocytes from DPPIV(+) F344 ra

241 While it has been well established that the fetal liver originates from foregut endoderm, the identi

242 all four PBDE congeners were highest in the fetal liver (p < 0.001), whereas median PBDE levels were

243 We determined MNR effects on fetal liver phosphoenolpyruvate carboxykinase 1 (protein

244 In this study, we report identification of a fetal liver population characterized phenotypically as L

245 cells derived from the Lin(-)CD45R(-)CD19(-) fetal liver population produce natural Ab that binds pne

246 DHT exposure, regardless of diet, decreased fetal liver Pparg mRNA expression and increased placenta

247 0 lymphoid genes and single-cell cultures of fetal liver precursor cells, we identified the common pr

248 the identification of a unique population of fetal liver progenitor cells in mice that can serve as a

249 Here, we show that human fetal liver progenitor cells self-assembled inside acell

250 tion of flt3l severely reduced the number of fetal liver progenitors and lymphoid tissue inducer cell

251 Mutant fetal liver progenitors generated B cells in situ but no

252 ) and periphery in chimeras established with fetal liver progenitors lacking Akt1 and/or Akt2.

253 from yolk sac erythromyeloid progenitors and fetal liver progenitors that seed tissues during embryog

254 Here we show that the differentiation of fetal liver progenitors to adult hepatocytes involves a

255 Fetal liver reconstitution experiments demonstrated that

256 olyadenylated RNA from differentiating mouse fetal liver red blood cells and identified 655 lncRNA ge

257 t induces hepatoprotective mechanisms in the fetal liver, reduces hepatic fatty acid synthase (Fas) e

258 Dynamic (11)C-verapamil brain or fetal liver (reporter of placental P-gp function) activi

259 aorta, vitelline and umbilical arteries, and fetal liver require or express Gata2.

260 . (2016) provide justification for transient fetal liver residence, where select bile acid compositio

261 eletion of the m(6)A writer METTL3 in murine fetal liver resulted in hematopoietic failure and perina

262 xamination of extruded erythroid nuclei from fetal liver revealed a striking depletion of most nuclea

263 Bright(-/-) embryonic day 12.5 (E12.5) fetal livers showed an increase in the expression of imm

264 e myeloid hematopoiesis in trisomy 21 at the fetal liver stage.

265 uman interleukin (IL)-10 gene into the total fetal liver stem cells (hIL-10-TFLs) of mice protects ag

266 Highly proliferative fetal liver stem/progenitor cells (FLSPCs) repopulate li

267 rosis/cirrhosis, but to a lesser extent than fetal liver stem/progenitor cells.

268 poietic stem and progenitor cells from mouse fetal liver, suggesting that enhancer activity is highly

269 e hematopoietic changes are also detected in fetal livers, suggesting that they are not the result of

270 Analysis of human fetal livers suggests that similar progenitors are prese

271 Definitive haematopoiesis in the fetal liver supports self-renewal and differentiation of

272 B lymphopoiesis begins in the fetal liver, switching after birth to the bone marrow, w

273 arent P50 values were significantly lower in fetal liver than in maternal liver for both gestation st

274 state in the adult bone marrow and embryonic fetal liver, the mechanism of HSC self-renewal has remai

275 rsor cells arise in the adult bone marrow or fetal liver, they migrate to the thymus where they rearr

276 l aorta and subsequently switch niche to the fetal liver through unknown mechanisms.

277 l is prepared by co-transplantation of human fetal liver, thymus and HSC.

278 Using human fetal liver tissue, we found that the mRNA of CYP26A1 an

279 ple of matched maternal serum, placenta, and fetal liver tissues during mid-gestation among a geograp

280 n primary sequence, were negligible in human fetal liver tissues or in the differentiating hESCs, and

281 lymphoid tissue inducer (LTi) cells from the fetal liver to the periphery, where they induce the form

282 tion of PIT1 in the hematopoietic system and fetal liver transplantation experiments demonstrated tha

283 ematopoietic cell TFPI that was generated by fetal liver transplantation.

284 In mixed chimeras with Scurfy fetal liver, Tregs derived from IFNAR KO bone marrow wer

285 Here we show that in the fetal liver versus bone marrow environment, reduced IL-7

286 ro-to-in vivo scaling, atRA clearance in the fetal liver was quantitatively minimal, thus providing a

287 rone hydroxylation, clearance of atRA in the fetal livers was mediated by CYP3A7.

288 liver soon after birth, and by extension the fetal liver, was metabolically active in lipoprotein met

289 at we trained on scRNAseq derived from human fetal liver, we identified a wide range of hPSC-derived

290 C-like cells with those generated within the fetal liver, we identified transcription factors and mol

291 frequency of hematopoietic stem cells in the fetal liver were observed on APAP treatment.

292 Subsequently 55 human fetal livers were analyzed.

293 Cells isolated from 12- to 14-d fetal livers were used to reconstitute irradiated recipi

294 mbryonic development, pHSCs migrate into the fetal liver, where they develop and mature to B cells in

295 rythroid progenitor cells of bone marrow and fetal liver, which disrupts erythropoiesis.

296 ages (Max Planck Institute cells) from mouse fetal liver, which reflect the innate immune characteris

297 matopoietic stem and progenitor cells to the fetal liver, while it hampers hematopoiesis in wild-type

298 hway are found primarily in the placenta and fetal liver, with significant androsterone levels also i

299 mbers are moderately increased in Tmod3(-/-) fetal livers, with only a slight increase in the 8N popu

300 island formation was impaired in Tmod3(-/-) fetal livers, with Tmod3 required in both erythroblasts